Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis

Overview of attention for article published in Regional Anesthesia & Pain Medicine, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 2,625)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 46 news outlets
blogs: 3 blogs
twitter: 25 X users

facebook: 1 Facebook page
reddit: 1 Redditor

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 11 Mendeley

Summary News Blogs X Facebook Reddit Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

Intranasal Ketamine Seems Effective for Refractory Chronic Migraine

Physician's Weekly, 04 Jun 2023

FRIDAY, June 2, 2023 (HealthDay News) — Intranasal ketamine seems effective for refractory chronic migraine, with about half of…

Aerosol nasal de ketamina es una alternativa prometedora para el tratamiento de la migraña

TekCrispy, 31 May 2023

Estudio destaca los beneficios del aerosol nasal de ketamina en la migraña crónica.

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

news-medical.net, 31 May 2023

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.